Intelligent Image Analysis for Drug Discovery


About us

Biocellvia proposes a new way to evaluate candidate molecules in preclinical assays. Drug development process takes around ten years and costs around one billion euros. Preclinical research is a key challenge for health industry. Biocellvia has developed a unique imaging technology that removes any variability and brings them optimal accuracy to get quantitative data.

Free Trial
Biocellvia has developed digital image analysis solutions for pre-clinical trials. It's a new way to elaborate your candidate molecules thanks to machine-learning based programs.

We have developed digital image analysis solutions based on machine-learning in order to evaluate lead molecules during pre-clinical assays.

Conventional methods had major limits and laborious to use. 
I understood straight away the advantage of numerical imaging for the industry. Our proprietary technology is based on machine-learning and fully-automated imaging analysis to optimize compound validation assay. This technology applicable to different pathologies, for a clearer decision-making.

Yvon Jule

This is a breakthrough innovation for pharmaceutical industry.

Our digital technology enables to evaluate candidate molecules during pre-clinical assays. These numerical tests have full benefits :
  • Independent-observer removing any variability
  • Optimal accuracy to get quantitative data
  • Machine-learning based programs
  • Our technology reduces delays and costs

Our research & development process enables us to propose available tests for more and more pathologies

Our compound validation assays are machine-learning based programs. We have developed artificial intelligence in order to improve studies' results in pre-clinical assays. Our tests are fully-automated and independent-observer.

The aim is to improve the accuracy and reliability of scientists' analysis and as a result your decision-making while respecting specific processes.

Biocellvia news

mai 14, 2018
Further validation for Biocellvia’s digital image analysis in new scientific article published by Gustave Roussy in collaboration with Biocellvia

Further validation for Biocellvia’s digital image analysis in new scientific article published by Gustave Roussy

Biocellvia is proud to announce its acknowledgement in the scientific article published in the European Respiratory Journal in April, in collaboration with the team at Gustave […]
avril 23, 2018
Biocellvia will take part to BIO18 : the 2018 BIO International Conference

Biocellvia will be at BIO18

Biocellvia will take part in the 2018 BIO International Convention which will take place in Boston from June 4th to 7th. The BIO International Convention is […]

Used in more than

6

countries


Since 2013

20000

samples analyzed


More than

15

years experience


1 technology

100%

reproducible